Clinical Trial Update: SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension [Phase 4]

View source ↗

Summary

The SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension (Phase 4) has completed and posted results evaluating the use of cabotegravir long-acting HIV pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2025-01-24